“EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024073, Aug. 2024, doi: 10.4084/MJHID.2024.073.